Company Name | Aquila Biomedical Limited |
---|---|
Company Status | Active |
Company Number | SC393914 |
Incorporation Date | 21 February 2011 (13 years, 3 months ago) |
Dissolution Date | — |
Category | Private Limited Company with Share Capital |
Previous Names | — |
Current Directors | 1 |
Business Industry | Professional, Scientific and Technical Activities |
---|---|
Business Activity | Research and Experimental Development On Biotechnology |
Latest Accounts | 31 December 2022 (1 year, 4 months ago) |
Next Accounts Due | 30 September 2024 (4 months, 1 week from now) |
Accounts Category | Audit Exemption Subsidiary |
Accounts Year End | 31 December |
Latest Return | 31 March 2024 (1 month, 3 weeks ago) |
Next Return Due | 14 April 2025 (10 months, 3 weeks from now) |
Registered Address | 2 James Lindsay Place Dundee DD1 5JJ Scotland |
---|---|
Shared Address | This company shares its address with 1 other company |
Constituency | Dundee West |
---|---|
County | — |
Accounts Year End | 31 December |
---|---|
Category | Audit Exemption Subsidiary |
Latest Accounts | 31 December 2022 (1 year, 4 months ago) |
Next Accounts Due | 30 September 2024 (4 months, 1 week from now) |
Latest Return | 31 March 2024 (1 month, 3 weeks ago) |
---|---|
Next Return Due | 14 April 2025 (10 months, 3 weeks from now) |
SIC Industry | Professional, scientific and technical activities |
---|---|
SIC 2007 (72110) | Research and experimental development on biotechnology |
15 October 2020 | Consolidated accounts of parent company for subsidiary company period ending 31/12/19 |
---|---|
2 October 2020 | Appointment of Mr Steven Francis Axtell Horder as a director on 18 September 2020 |
2 October 2020 | Termination of appointment of Matthew James Hanson as a director on 18 September 2020 |
28 September 2020 | Notice of agreement to exemption from audit of accounts for period ending 31/12/19 |
28 September 2020 | Audit exemption statement of guarantee by parent company for period ending 31/12/19 |